DK1485377T5 - Pyranoner egnede som ATM-inhibitorer - Google Patents

Pyranoner egnede som ATM-inhibitorer

Info

Publication number
DK1485377T5
DK1485377T5 DK03742608.7T DK03742608T DK1485377T5 DK 1485377 T5 DK1485377 T5 DK 1485377T5 DK 03742608 T DK03742608 T DK 03742608T DK 1485377 T5 DK1485377 T5 DK 1485377T5
Authority
DK
Denmark
Prior art keywords
pyranones
atm inhibitors
sulfonamino
acylamido
prodrugs
Prior art date
Application number
DK03742608.7T
Other languages
English (en)
Other versions
DK1485377T3 (da
Inventor
Graeme C M Smith
Niall M B Martin
Stephen P Jackson
Mark J O'connor
Alan Y K Lau
Ian Timothy Williams Matthews
Keith Allan Menear
Laurent Jean Martin Rigoreau
Marc Geoffrey Hummersone
Roger John Griffin
Xiao-Ling Fan Cockcroft
Original Assignee
Kudos Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0204350.3A external-priority patent/GB0204350D0/en
Application filed by Kudos Pharm Ltd filed Critical Kudos Pharm Ltd
Publication of DK1485377T3 publication Critical patent/DK1485377T3/da
Application granted granted Critical
Publication of DK1485377T5 publication Critical patent/DK1485377T5/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
DK03742608.7T 2002-02-25 2003-02-24 Pyranoner egnede som ATM-inhibitorer DK1485377T5 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0204350.3A GB0204350D0 (en) 2002-02-25 2002-02-25 ATM inhibitors
US39588402P 2002-07-15 2002-07-15
PCT/GB2003/000770 WO2003070726A1 (en) 2002-02-25 2003-02-24 Pyranones useful as atm inhibitors

Publications (2)

Publication Number Publication Date
DK1485377T3 DK1485377T3 (da) 2010-04-19
DK1485377T5 true DK1485377T5 (da) 2010-12-06

Family

ID=27758841

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03742608.7T DK1485377T5 (da) 2002-02-25 2003-02-24 Pyranoner egnede som ATM-inhibitorer

Country Status (20)

Country Link
EP (2) EP2174939A1 (da)
JP (1) JP2005521689A (da)
CN (1) CN100358891C (da)
AT (1) ATE451365T1 (da)
AU (1) AU2003209990B8 (da)
BR (1) BR0307944A (da)
CA (1) CA2473100A1 (da)
CY (1) CY1109835T1 (da)
DE (1) DE60330442D1 (da)
DK (1) DK1485377T5 (da)
ES (1) ES2336206T3 (da)
GB (1) GB2401606B (da)
HK (1) HK1069827A1 (da)
MX (1) MXPA04007809A (da)
NO (1) NO329806B1 (da)
NZ (1) NZ534821A (da)
PL (1) PL370074A1 (da)
PT (1) PT1485377E (da)
SI (1) SI1485377T1 (da)
WO (1) WO2003070726A1 (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7151102B2 (en) 2000-10-30 2006-12-19 Kudos Pharmaceuticals Limited Phthalazinone derivatives
GB0119863D0 (en) 2001-08-14 2001-10-10 Cancer Res Campaign Tech DNA-PK inhibitors
GB0119865D0 (en) 2001-08-14 2001-10-10 Cancer Res Campaign Tech DNA-PK inhibitors
US7196085B2 (en) 2002-04-30 2007-03-27 Kudos Pharmaceuticals Limited Phthalazinone derivatives
US7413738B2 (en) 2002-08-13 2008-08-19 Enzon Pharmaceuticals, Inc. Releasable polymeric conjugates based on biodegradable linkers
US7122189B2 (en) * 2002-08-13 2006-10-17 Enzon, Inc. Releasable polymeric conjugates based on aliphatic biodegradable linkers
US7449464B2 (en) 2003-03-12 2008-11-11 Kudos Pharmaceuticals Limited Phthalazinone derivatives
GB0305681D0 (en) 2003-03-12 2003-04-16 Kudos Pharm Ltd Phthalazinone derivatives
EP1618386A2 (en) * 2003-05-01 2006-01-25 Kudos Pharmaceuticals Limited Methods and means for the treatment of disorders associated with cellular senescence
CN1867566B (zh) * 2003-08-13 2010-06-16 库多斯药物有限公司 氨基吡喃酮和它们作为atm抑制剂的用途
CN102107008B (zh) 2003-12-01 2013-04-03 库多斯药物有限公司 用于治疗癌症的dna损伤修复抑制剂
WO2005118543A1 (ja) * 2004-06-03 2005-12-15 Ono Pharmaceutical Co., Ltd. キナーゼ阻害薬およびその用途
US7402607B2 (en) 2004-09-20 2008-07-22 Kudos Pharmaceuticals Limited DNA-PK inhibitors
TW200638938A (en) * 2005-02-09 2006-11-16 Kudos Pharm Ltd ATM inhibitors
AR053358A1 (es) 2005-04-15 2007-05-02 Cancer Rec Tech Ltd Inhibidores de adn - pk
TW200745094A (en) * 2005-08-31 2007-12-16 Kudos Pharm Ltd ATM inhibitor
GB0521373D0 (en) 2005-10-20 2005-11-30 Kudos Pharm Ltd Pthalazinone derivatives
AU2008299721A1 (en) 2007-09-14 2009-03-19 Astrazeneca Ab Phthalazinone derivatives
HUE030800T2 (en) 2008-10-07 2017-05-29 Astrazeneca Uk Ltd Pharmaceutical Form No. 514
EP2486923B1 (en) * 2011-02-11 2015-09-09 Dr. Felix Jäger und Dr. Stefan Drinkuth Laborgemeinschaft OHG Histone deacetylase (HDAC) inhibiting compounds and method of making same
JP2014527036A (ja) 2011-06-27 2014-10-09 ザ ジャクソン ラボラトリー 癌および自己免疫疾患の処置のための方法および組成物
EP3042900B1 (en) 2013-08-29 2020-09-23 Fujifilm Corporation Novel morpholine derivative or salt thereof
WO2021260580A1 (en) 2020-06-24 2021-12-30 Astrazeneca Uk Limited Combination of antibody-drug conjugate and atm inhibitor
CN112094210A (zh) * 2020-09-24 2020-12-18 江苏扬农化工股份有限公司 一种取代的亚磺酸盐的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4282155A (en) * 1980-02-04 1981-08-04 Merck & Co., Inc. Antihypercholesterolemic compounds
DE68914495T2 (de) * 1988-03-02 1994-10-27 Merck & Co Inc Antihypercholesterolemisches Mittel.
WO1992000290A1 (en) * 1990-06-29 1992-01-09 The Upjohn Company Antiatherosclerotic and antithrombotic 2-amino-6-phenyl-4h-pyran-4-ones
IL129871A (en) * 1994-05-06 2003-11-23 Pharmacia & Upjohn Inc Process for preparing 4-phenyl-substituted octanoyl-oxazolidin-2-one intermediates that are useful for preparing pyran-2-ones useful for treating retroviral infections
JP3851661B2 (ja) * 1996-05-14 2006-11-29 第一製薬株式会社 新規生理活性物質及びその製造方法
FR2765579A1 (fr) * 1997-07-01 1999-01-08 Lipha Nouveaux derives de 4-hydroxy-2h-1-(thio)pyran-2-ones leurs preparations et leurs utilisations comme rodonticides
AU743920B2 (en) * 1997-09-26 2002-02-07 Toray Industries, Inc. Cyclic ketone derivative and pharmaceutical use thereof
AU756965B2 (en) * 1998-03-12 2003-01-30 Microbial Chemistry Research Foundation Benzofurylpyrone derivatives

Also Published As

Publication number Publication date
ES2336206T9 (es) 2011-03-24
NO20044063L (no) 2004-09-24
DK1485377T3 (da) 2010-04-19
EP1485377A1 (en) 2004-12-15
CN100358891C (zh) 2008-01-02
ES2336206T3 (es) 2010-04-09
HK1069827A1 (en) 2005-06-03
JP2005521689A (ja) 2005-07-21
NZ534821A (en) 2006-07-28
CN1639154A (zh) 2005-07-13
SI1485377T1 (sl) 2010-04-30
GB2401606B (en) 2005-08-31
EP1485377B8 (en) 2010-02-24
GB0419534D0 (en) 2004-10-06
PT1485377E (pt) 2010-03-12
GB2401606A (en) 2004-11-17
AU2003209990B2 (en) 2008-10-09
NO329806B1 (no) 2010-12-20
EP2174939A1 (en) 2010-04-14
MXPA04007809A (es) 2004-10-15
EP1485377B1 (en) 2009-12-09
DE60330442D1 (de) 2010-01-21
EP1485377B9 (en) 2010-10-06
BR0307944A (pt) 2005-02-01
CA2473100A1 (en) 2003-08-28
AU2003209990B8 (en) 2008-10-30
ATE451365T1 (de) 2009-12-15
AU2003209990A1 (en) 2003-09-09
CY1109835T1 (el) 2014-09-10
WO2003070726A1 (en) 2003-08-28
PL370074A1 (en) 2005-05-16

Similar Documents

Publication Publication Date Title
HK1069827A1 (en) Pyranones useful as atm inhibitors.
NO20061126L (no) Aminopyroner og deres anvendelse som ATM-inhibitorer
BR0316241A (pt) Pirrolobenzodiazepinas
HUP0301607A2 (hu) Szelektív neurokinin antagonista hatású nitrogéntartalmú heterociklusos vegyületek, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
HRP20070307T3 (en) Derivatives of n-[ phenyl(pyrrolidine-2-yl)methyl]benzamide and n-[ (azepan-2-yl)phenylmethyl]benzamide, preparation method thereof and application of same in therapeutics
ME00411B (me) Nova jedinjenja koja imaju inhibitorno dejstvo na transporter glukoze zavistan od natrijuma
UY26727A1 (es) Derivados de tropano útiles en terapia
RS51674B (en) PIPERIDIN-4-IL-PIRIDAZIN-3-ILAMINE DERIVATIVES AS A FAST DISSOCATING DOPAMIN 2 RECEIVER ANTAGONISTS
RS51193B (sr) Hidantoinski derivati korisni kao inhibitori metaloproteinaza
UA88329C2 (en) Dna-pk inhibitors
HRP20070286T3 (en) Substituted diketopiperazines and their use as oxytocyn antagonists
DK1157998T3 (da) Heterocykliske forbindelser, mellemprodukter derfor og elastaseinhibitorer
ATE374750T1 (de) Serotoninwiederaufnahme-inhibitoren
AR057558A1 (es) Compuestos de cinolincarboxamida y composicion farmaceutica
ES2064057T3 (es) Unos derivados de 2-(aminoalquil)-5-(arilalquil)-1,3-dioxanos, su preparacion y su aplicacion en terapeutica.
HRP20020440B1 (en) 1-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof
UY26568A1 (es) Nuevos derivados de amidas heterocíclicas
DE60202575D1 (de) 3,4-Dihydro-1H-Naphthalin-Derivate als hoch selektive Cyclooxygenase-2-Inhibitoren
IL178548A0 (en) Derivatives of 14,15-dihydro 20,21-dinoreburnamenin-14-ol, and applications thereof
TR200402333T4 (tr) Artropodisidal karboksanilidler